Status:
COMPLETED
Cardiac Sarcoidosis and FDG-PET
Lead Sponsor:
Kurume University
Conditions:
Sarcoidosis
Dilated Cardiomyopathy
Eligibility:
All Genders
35-85 years
Brief Summary
Sarcoidosis is a multi-systemic inflammatory disorder of unknown cause characterized by the formation of non-caseating granulomas in involved organs. Its cardiac involvement may be potentially fatal. ...
Detailed Description
Fasting FDG-PET will be performed in all subjects. Serum calcium, C-reactive protein (CRP), angiotensin converting enzyme (ACE), lysozyme, and B-type natriuretic peptide (BNP) levels will be measured ...
Eligibility Criteria
Inclusion
- Subjects between the ages of 35 and 85 years
- Subjects with systemic sarcoidosis
- Subjects with idiopathic sarcoidosis
Exclusion
- Subjects with active inflammatory diseases not related to sarcoidosis
- Subjects with coronary artery disease and primary valvular heart diseases
- Subjects with uncontrolled diabetes mellitus or insulin treatment
- Subjects with use of the corticosteroid
- Subjects with systemic disorders such as active inflammatory, liver, renal, hematopoietic, and malignant disease
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00958087
Start Date
March 1 2004
End Date
July 1 2010
Last Update
September 27 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kurume University Hospital
Kurume, Japan, 830-0011